Scientists take a (small) step toward universal antivenom; Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Taking stock of the drug industry, from the lab to the medicine chest

February 21, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Mark Ralston/AFP/Getty Images STAT+ | Scientists take a (small) step toward universal antivenom Snakebites kill 100,000 worldwide each year. In a new paper, scientists report a blueprint for creating a "universal antivenom." By Jason Mast STAT+ | Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff The move comes as another Flagship startup has let go of a third of its staff, part of a broader hunkering down by platform companies. By Jason Mast Opinion: How Medicare leaves Puerto Ricans behind Puerto Ricans are tax-paying American citizens, but they are left out of many of Medicare's most important programs. By Mariela Torres Cintrón

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser